Quick Answer
Glucotrack, Inc. reported Operating Income Loss of -$16.09 million for the year ending 2025.
- Glucotrack, Inc. showed a decrease of -10.6% in Operating Income Loss from 2024 to 2025.
- This data is from Glucotrack, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: -$539.1 thousand | Q3 2011: -$700.2 thousand | Q1 2012: -$648.0 thousand | Q2 2012: -$754.1 thousand | Q3 2012: -$686.0 thousand | Q1 2013: -$687.8 thousand | Q2 2013: -$831.8 thousand | Q3 2013: -$727.4 thousand | Q1 2014: -$887.2 thousand | Q2 2014: -$882.3 thousand | Q3 2014: -$830.7 thousand | Q1 2015: -$880.7 thousand | Q2 2015: -$1.10 million | Q3 2015: -$1.12 million | Q1 2016: -$1.26 million | Q2 2016: -$1.58 million | Q3 2016: -$1.49 million | Q1 2017: $2.60 million | Q2 2017: -$2.65 million | Q3 2017: -$2.65 million | Q1 2018: $1.91 million | Q2 2018: -$2.01 million | Q3 2018: -$1.61 million | Q1 2019: $1.03 million | Q2 2019: -$894.3 thousand | Q3 2019: -$980.5 thousand | Q1 2020: -$756.0 thousand | Q2 2020: -$611.0 thousand | Q3 2020: -$887.0 thousand | Q1 2021: -$896.0 thousand | Q2 2021: -$873.0 thousand | Q3 2021: -$767.0 thousand | Q1 2022: -$1.09 million | Q2 2022: -$1.12 million | Q3 2022: -$929.0 thousand | Q1 2023: -$1.28 million | Q2 2023: -$1.18 million | Q3 2023: -$2.22 million | Q1 2024: -$2.95 million | Q2 2024: -$4.49 million | Q3 2024: -$3.25 million | Q1 2025: -$3.50 million | Q2 2025: -$4.80 million | Q3 2025: -$4.31 million.
- Over the full 17 years of available data (2009 to 2025), Glucotrack, Inc.'s Operating Income Loss has declined by 1,274.9%.
- Historical annual values: Fiscal year 2025: -$16.09 million | Fiscal year 2024: -$14.55 million | Fiscal year 2023: -$7.10 million | Fiscal year 2022: -$4.43 million | Fiscal year 2021: -$4.04 million | Fiscal year 2020: -$3.13 million | Fiscal year 2019: $3.51 million | Fiscal year 2018: -$6.54 million | Fiscal year 2017: $10.58 million | Fiscal year 2016: -$5.66 million | Fiscal year 2015: -$4.66 million | Fiscal year 2014: -$3.61 million | Fiscal year 2013: -$3.03 million | Fiscal year 2012: -$2.77 million | Fiscal year 2011: -$2.33 million | Fiscal year 2010: -$1.39 million | Fiscal year 2009: -$1.17 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: